The Anti-Infective Innovator Blog

NASDAQ Spotlight Interview of Spero CEO, Ankit Mahadevia, MD

NASDAQ Spotlight Interview of Spero CEO, Ankit Mahadevia, MD

The Anti-Infective Innovator Blog
Posted on
September 25, 2019
Written by Spero Therapeutics,
Nasdaq Spotlight